India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
RARE-DISEASE DRUGS AS INDIA’S NEXT PHARMA FRONTIER Syllabus: GS-3: Issues related to development and management of social Sectors- Health GS 3: Research And Development Why in the News? India is exploring how its pharmaceutical manufacturing strength, large patient population, and evolving rare-disease policy can be leveraged to make expensive orphan drugs more accessible while creating …
Read MoreSEMAGLUTIDE GENERICS EXPAND INDIA’S GLP-1 DRUG MARKET Why in the News? The launch of generic versions of semaglutide has led to a 75% rise in sales of GLP-1 drugs in India within one month. Sales volume of semaglutide increased from 25,000 units in February to 1.7 lakh units in April 2026 after patent expiry of …
Read MoreSyllabus: GS-3 :India’s Pharmaceutical industry , localization and related trade Focus : The article delves into the recent policy shifts led by the Central Drugs Standard Control Organisation (CDSCO) regarding the centralization of licensing authority for export drugs in India’s pharmaceutical industry. It examines the potential ramifications of these changes on India’s global pharmaceutical standing, …
Read More
